8-KOther Events

HCA Healthcare, Inc. 8-K Report (Sep 25, 2002)

Filed September 25, 2002For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K report on September 24, 2002, disclosing details related to the issuance and sale of $500 million in aggregate principal amount of its 6.30% Notes due 2012. This transaction, conducted under the Securities Act of 1933, involved the execution of an underwriting agreement and the specific terms of the notes. This filing is significant for investors as it pertains to a substantial debt offering. The issuance of these notes indicates HCA's intention to raise capital, likely for general corporate purposes, potential acquisitions, or refinancing existing debt. Investors should note the coupon rate of 6.30% and the maturity date of 2012, which provide insights into the company's cost of capital and long-term financial strategy.

Key Highlights

  • 1HCA Healthcare, Inc. successfully issued $500 million in aggregate principal amount of 6.30% Notes due 2012.
  • 2The debt offering was conducted under the Securities Act of 1933, indicating compliance with federal securities regulations.
  • 3The company entered into an Underwriting Agreement Standard Provisions (Debt Securities) dated September 18, 2002.
  • 4A specific Underwriting Agreement (Terms) was also executed on September 18, 2002, detailing the arrangement with the underwriters.
  • 5The issuance consists of two tranches: a $400 million note and a $100 million note, both maturing in 2012 with a 6.30% coupon.
  • 6This filing provides transparency to investors regarding a significant capital-raising event for HCA.

Frequently Asked Questions

This 8-K filing is primarily to report on the issuance and sale of $500 million of HCA's 6.30% Notes due 2012 and to provide related documentation as exhibits, such as the underwriting agreements and the note indentures.

HCA issued $500 million in aggregate principal amount of 6.30% Notes due 2012. The notes are comprised of a $400 million series and a $100 million series, both carrying a 6.30% annual interest rate and maturing in 2012.

The issuance of $500 million in long-term debt suggests HCA is looking to raise capital. This capital could be used for various strategic initiatives such as funding operations, pursuing acquisitions, investing in facilities, or refinancing existing debt obligations, thereby impacting its capital structure and financial leverage.

Investors can find more details by reviewing the exhibits filed with this 8-K report, specifically the Underwriting Agreement Standard Provisions, the Underwriting Agreement (Terms), and the actual note indentures for the $400 million and $100 million notes due 2012.